Navigation Links

Medicine News

Diversity Focus Announces Partnership with BlendCard

1/15/2014
(PRWEB) January 15, 2014 We live in a unique time where the concept “Buy Local” is becoming more and more important. Local businesses and even governments have looked for and established ways to promote the local economy. With that in mind, Diversity Focus is excited to announce a partnership with BlendCard. This collaboration enhances diversity and promotes inclusive communities by creatin... [Comments]

Kirk Manzo of The Manzo Group Announces New Affiliation with The John Maxwell Team

1/15/2014
Atlanta, GA (PRWEB) January 15, 2014 The Manzo Group, a sales training and consulting firm based in Atlanta, Ga., announces its affiliation with the John Maxwell Team for coaching, training and speaking on the areas of communication and leadership programs. With programs designed specifically for the automotive industry, the Manzo Group aims at attracting new and used car dealerships in... [Comments]

Dr. Leigh Ann Scott to Open Irving Office to Provide Bio-Identical Hormone Therapy

1/15/2014
Dallas, TX (PRWEB) January 15, 2014 Dr. Leigh Ann Scott has announced the opening of her new office in Irving to provide Bio-identical Hormone Replacement Therapy. “Bio-identical hormones are a vital treatment option and medical science supports their use in improving overall health while diminishing the effects of aging. Most patients are surprised at how helpful they can be as part of an... [Comments]

Dr. Yonatan Mahller Joins DoctorsElite as a New Member

1/15/2014
Gulfport, MS (PRWEB) January 15, 2014 DoctorsElite, a site that helps patients around the United States locate doctors by diagnosis, treatment, and specialty, has announced the addition of Dr. Yonatan Mahller to their growing physician membership. Dr. Mahller's expertise in OB/GYN medicine is a welcome addition to the site's ranks of medical specialists. Dr. Yonatan Mahller was... [Comments]

Phase II trial of Bevacizumab (Avastin) in locally advanced cervical cancer 'promising'

1/15/2014
An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advan... [Comments]Phase II trial of Bevacizumab (Avastin) in locally advanced cervical cancer 'promising'

Resisting the flu

1/15/2014
McGill researchers, led by Dr. Maya Saleh of the Department of Medicine, have identified an enzyme, cIAP2 that helps the lungs protect themselves from the flu by giving them the ability to resist tissue damage. "It's a discovery that offers exciting new avenues for controlling influenza, since u... [Comments]Resisting the flu

Nationwide minimally invasive surgery rates triple for pancreatic disease

1/15/2014
Researchers at University of California, San Diego School of Medicine report a three-fold increase in the use of minimally invasive surgery (MIS) across the nation for patients with pancreatic disease. Although adaptation of MIS for this difficult-to-reach gland is recent, the growing trend... [Comments]Nationwide minimally invasive surgery rates triple for pancreatic disease

Iskream is Proud to Announce a Partnership with HMA-Hearst Media Agency

1/15/2014
Milford, CT (PRWEB) January 15, 2014 Iskream is proud to announce a partnership with Hearst Media Agency. As part of the campaign, Hearst will develop and distribute news content in the form of frequent press releases through the largest online PR channel in the world. Iskream is a low-fat, gluten-free , no-sugar-added ice cream made with stevia. Iskream engaged Hearst Media Services t... [Comments]

Medicine Products

Osteomesh Bioresorbable Implant for Craniofacial Surgery

Description:Osteomesh is a bioresorbable implant used in craniofacial surgery to repair various types of fractures, like the orbital floor fracture and to fill surgical defects. It has interconnected pores which allow rapid saturation with marrow, blood and nutrients, thus providing the patients own cells with chemical signals that are required for bone growth and remodeling. The mesh is malleable and can be...
Company:Osteopore International

AMD Now

Description:AMD Now is a forum presenting interactive education on Age- related Macular Degeneration (AMD), AMD diagnosis and treatments, VEGF, aseptic technique and supportive care for patients and caregivers....
Company:ASORN

SWISSBLADE Diamond Surgical Knives

Description:SWISSBLADE disposable surgical knives single-use blades deliver a consistent, sharp, clean cut due to the low friction coefficient achieved with Ziemers proprietary coating technology. SWISSBLADE diamond surgical knives feature top-of-the-line, reusable blades with the proven superior cutting capabilities based on the diamond expertise of Ziemer Group partner Meyco (Biel, Switzerland) an...
Company:ZIEMER USA, Inc.

MAXWELL Optical Wavefront Aberrometer

Description:The MAXWELL Optical Wavefront Aberrometer is an innovative diagnostic instrument with a wide range of functions that permit eye care practitioners and researchers to effectively assess all of the wavefront aberrations present in a subjects eye. This remarkable device offers the widest wavefront diagnostic range and functions on more than 99% of subjects. Beyond its superior performance in wavefro...
Company:ZIEMER USA, Inc.

ConstaVac CBCII Blood Conservation System

Description:The Stryker CBCII Blood Conservation System provides a safe, simple and economic disposable system for blood reinfusion....
Company:Stryker Instruments

Medicine Technology

Sono-Tek Announces Third Quarter Results

1/15/2014
MILTON, N.Y. , Jan. 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today announced sales of  $2,650,000 for the three months ended November 30, 2013, compared to sales of $2,202,000 for the prior year period, an increase of $448,000 or 20%. Once again, this quarter has also shown growth over the preceding quarter's sales, continuing a trend that began in the first quarter o... [Comments]

Orthopedic Instrument Industry in China Markets Forecast to 2015

1/15/2014
DALLAS , Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" research report to its store . (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging of population, consumption upgrade and policy support, China's orthopedic instrument industry has seen rapid development over the ye... [Comments]

Mission Pharmacal Conducts Online Survey of Osteoporosis Patients

1/15/2014
SAN ANTONIO , Jan. 15, 2014 Most osteoporosis patients want a choice in the medication they take, according to a recent online survey* sponsored by Mission Pharmacal Company. The survey, conducted by Inspire among the National Osteoporosis Foundation online support community, revealed that 74 percent of osteoporosis patients surveyed prefer to take medication that comes in a... [Comments]

Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018

1/15/2014
DUBLIN , Jan. 15, 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the addition of the "Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Dental consumables are product... [Comments]

Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest

1/15/2014
GRAND RAPIDS, Mich. , Jan. 15, 2014 As health officials across the Midwest warn against the widespread reach of the flu virus, select Meijer pharmacies in Michigan will offer free diagnostic testing for influenza and strep throat to eligible patients, enabling Meijer pharmacists to administer tests and, in some cases, fill the matching prescriptions, under strict protocol... [Comments]

(Date:4/22/2014)... Jersey Institute of Technology (NJIT) today to join ... of the New Jersey Innovation Institute (NJII), an ... business innovation through the leveraging of industry, government, ... Cory Booker, Panasonic Corp. of North America Chairman ... Kim Guadagno, New Jersey Secretary of Higher Education ...
(Date:4/22/2014)... DALLAS April 22, 2014 Researchers at UT ... people suffering from depression . , A ... major mechanism by which ghrelin (a hormone with natural ... identified a potentially powerful new treatment for depression in ... , The study, published online in April,s ...
(Date:4/22/2014)... Washington, DC (April 22, 2014) The International ... May 22-26 in Seattle, Washington. The theme of ... life" means in a networked and digital society. ... and attended by over 2,200 Communication scholars representing ... largest scholarly international communication conference in the world. ...
(Date:4/22/2014)... 22 April 2014. The latest scientific advances and emerging ... Failure 2014, the main annual meeting of the Heart ... (ESC). Journalists will also hear breaking news on acute ... Heart Failure, which is part of the main congress. ... Athens, Greece, at the Megaron Athens International Conference Centre ...
(Date:4/22/2014)... ARBOR, Mich. Nearly 7 in 10 Americans ... a new national survey by researchers at the University ... with children under the age of 18 at home, ... more likely than other adults to support universal coverage ... appear in the Journal of the American Medical ...
Breaking Medicine News(10 mins):Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2Health News:The world's largest heart failure congress 2Health News:The world's largest heart failure congress 3Health News:More than two-thirds of Americans support mandated coverage of birth control in health plans 2
... 11, 2008 The American Cancer Society announced today ... for Exemplary Leadership in Tobacco Control. The awards are ... L. Terry, M.D., who led the landmark 1964 Surgeon ... and other illnesses. Dr. Terry,s courageous and groundbreaking work ...
... Deanna Vankessel, author of the recently published G lobal Markets ... to offer extensive expertise on the recent FDA premarket approval recommendation of ... , , MRG,s Deanna Vankessel is available ... , How ...
... Begin in December - , , ... Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), ... neratinib (HKI-272) in women with advanced HER-2-positive breast cancer. These ... breast cancer positive for the ErbB-2 receptor (also known as HER-2 ...
... Health Company (NYSE Alternext: FHC) has announced that the U.S. ... Committee has unanimously voted that the company,s second-generation female condom, ... , , The Advisory ... condition that the FC2 Female Condom,s instructions for use continue ...
... with ribavirin for previously untreated children with chronic hepatitis ... , KENILWORTH, N.J., Dec. 12 Schering-Plough ... the U.S. Food and Drug Administration (FDA) has granted ... USP) combination therapy for use in previously untreated patients ...
... Case Medical Center in conjunction with Sodexo Health Care Services ... 24/6 unit, the original certified kosher hot food vending machine. ... in the state of Ohio, offering patients and their caregivers ... , University Hospitals prides itself ...
Cached Medicine News:Health News:American Cancer Society recognizes international tobacco control leaders 2Health News:American Cancer Society recognizes international tobacco control leaders 3Health News:American Cancer Society recognizes international tobacco control leaders 4Health News:American Cancer Society recognizes international tobacco control leaders 5Health News:American Cancer Society recognizes international tobacco control leaders 6Health News:Millennium Research Group Analyst Available to Comment on FDA's Premarket Approval Recommendation of Genzyme Biosurgery's Synvisc Single-Injection Product for the Knee 2Health News:Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer 2Health News:Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer 3Health News:Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer 4Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 2Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 3Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 4Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 5Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 2Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 3Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 4Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 5Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 6Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 7Health News:University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine 2Health News:University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine 3
... has been designed specifically for the ... involved in ward rounds. It is ... dosages, and consultations that are requested ... Registrar during Ward round examinations and ...
... tracking and billing. This ... Handheld application, a complete ... CPT™ and ICD-9-CM codes ... Designed for any medical ...
In addition to the patient data OB-on-Call contains a comprehensive Medications list displaying related drugs by brand name, generic title, and usage description notes....
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
Medicine Products:
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North America,s ... of high-value chemistry, will hold the 30 th edition ... Convention Center from January 21-24. (Logo: ... from top pharmaceutical, fine chemical and specialty chemical companies will ...
(Date:1/14/2014)... HARRISBURG, Pa. , Jan. 14, 2014 Dynamic Healthcare ... ("GMH"), announced today that it acquired Progressive Home Medical Equipment, ... January 7, 2014. The terms of the acquisition were not ... medical equipment ("DME") company providing a wide range of sleep, ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a ... Leesburg, Virginia is the first in ... chamber. Dr. Susan M. Barnes , Medical ... Barnes and husband, Dr. Cole Taylor , are avid scuba ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
... MITI ), a biopharmaceutical company developing novel, ... autoimmune,diseases, announced the start of a phase 1 ... will explore the safety, pharmacokinetics,pharmacodynamics and anti-tumor activity ... MT110 targets the epithelial cell adhesion molecule ...
... an oncolytic product, WOBURN, Mass., April 22 ... treatments for cancer and the prevention,of infectious disease, ... (FDA) has approved the design of a single, ... OncoVEX(GM-CSF) in,previously treated patients with metastatic melanoma. The ...
Cached Medicine Technology:Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors 2Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors 3Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors 4Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors 5BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO 2BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO 3

Microsoft VBScript runtime error '800a01f4'

Variable is undefined: 'fe'

/inc/ab_right.asp, line 979